|
GB1454864A
(en)
|
1974-03-05 |
1976-11-03 |
Wyeth John & Brother Ltd |
Thioureas
|
|
PT72878B
(en)
|
1980-04-24 |
1983-03-29 |
Merck & Co Inc |
Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
|
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
CA2090283A1
(en)
|
1992-02-28 |
1993-08-29 |
Nobuyuki Hamanaka |
Phenoxyacetic acid derivatives
|
|
US5516652A
(en)
|
1993-10-06 |
1996-05-14 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor IP
|
|
JP3692536B2
(ja)
|
1994-02-10 |
2005-09-07 |
小野薬品工業株式会社 |
プロスタグランジンｉ２受容体
|
|
WO1996035713A1
(en)
|
1995-05-08 |
1996-11-14 |
Pfizer, Inc. |
Dipeptides which promote release of growth hormone
|
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
|
DE19834047A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituierte Pyrazolderivate
|
|
UA71586C2
(en)
|
1998-12-04 |
2004-12-15 |
Smithkline Beecham Corp |
A vitronectin receptor antagonist
|
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
|
SK287418B6
(sk)
|
1999-05-04 |
2010-09-07 |
Schering Corporation |
Farmaceutický prípravok s obsahom CCR5 antagonistov a súprava s obsahom tohto prípravku
|
|
KR100439357B1
(ko)
|
1999-05-04 |
2004-07-07 |
쉐링 코포레이션 |
Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체
|
|
GB9914255D0
(en)
|
1999-06-18 |
1999-08-18 |
Lilly Forschung Gmbh |
Pharmaceutical compounds
|
|
EG24179A
(en)
|
1999-09-07 |
2008-09-28 |
Smithkline Beecham Corp |
Vitronectin receptor antagonists
|
|
DE19943634A1
(de)
|
1999-09-13 |
2001-04-12 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
DE19943639A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
|
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
DE19943636A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
ES2316383T3
(es)
|
1999-09-17 |
2009-04-16 |
Millennium Pharmaceuticals, Inc. |
Benzamidas e inhibidores relacionados del factor xa.
|
|
PL355011A1
(en)
|
1999-11-08 |
2004-03-22 |
Merck & Co, Inc. |
Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists
|
|
US6822102B2
(en)
|
2000-01-03 |
2004-11-23 |
Pharmacia Corporation |
Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
|
|
IL150963A0
(en)
|
2000-02-08 |
2003-02-12 |
Smithkline Beecham Corp |
Method and compositions for treating an inflammatory disease
|
|
KR100523119B1
(ko)
*
|
2000-03-16 |
2005-10-20 |
에프. 호프만-라 로슈 아게 |
Ｉｐ 길항제로서의 카복실산 유도체
|
|
AR031176A1
(es)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
Nuevos derivados de pirazolpiridina sustituidos con piridina
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
TWI316055B
(https=)
|
2001-04-26 |
2009-10-21 |
Nippon Shinyaku Co Ltd |
|
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
|
TW200305423A
(en)
|
2002-02-14 |
2003-11-01 |
Ono Pharmaceutical Co |
N-carbamoyl nitrogen-containing condensed ring compound and medicament containing same as active ingredient
|
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2497903A1
(en)
|
2002-09-18 |
2004-04-01 |
Ono Pharmaceutical Co., Ltd. |
Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
|
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規６−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規１−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
JP2007524596A
(ja)
|
2003-02-28 |
2007-08-30 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
共結晶医薬組成物
|
|
CA2518443A1
(en)
|
2003-03-12 |
2004-09-30 |
Abbott Laboratories |
Naphthyridine derivatives as antibacterial agents
|
|
MXPA05011523A
(es)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Heteroarilos sustituidos como inhibidores de proteinas de tirosina fosfatasas.
|
|
WO2005020926A2
(en)
|
2003-08-28 |
2005-03-10 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
|
|
US7420059B2
(en)
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
AU2004309420B2
(en)
|
2003-12-23 |
2008-10-30 |
Novartis Ag |
Bicyclic heterocyclic p-38 kinase inhibitors
|
|
GB0413960D0
(en)
|
2004-06-22 |
2004-07-28 |
Novartis Ag |
Organic compounds
|
|
AR051780A1
(es)
|
2004-11-29 |
2007-02-07 |
Japan Tobacco Inc |
Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
|
|
EP2392328A1
(en)
|
2005-05-09 |
2011-12-07 |
Hydra Biosciences, Inc. |
Compounds for modulating TRPV3 Function
|
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
|
RU2008110908A
(ru)
|
2005-08-25 |
2009-09-27 |
Шеринг Корпорейшн (US) |
Производные имидазола в качестве функционально селективных агонистов альфа2с адренорецепторов
|
|
GB0601951D0
(en)
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
|
US7541371B2
(en)
|
2006-02-20 |
2009-06-02 |
Eisai R&D Management Co., Ltd. |
Method for treating a motor neuron disease
|
|
US20080064871A1
(en)
|
2006-05-26 |
2008-03-13 |
Japan Tobacco Inc. |
Production Method of Nitrogen-Containing Fused Ring Compounds
|
|
US20080305169A1
(en)
|
2006-05-26 |
2008-12-11 |
Japan Tobacco Inc. |
Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
|
|
US8163817B2
(en)
|
2007-05-11 |
2012-04-24 |
Canon Kabushiki Kaisha |
Aqueous ink, ink set, image forming method and image forming apparatus
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
WO2009005672A1
(en)
*
|
2007-06-29 |
2009-01-08 |
Merck & Co., Inc. |
Antidiabetic azaindoles and diazaindoles
|
|
ES2372908T3
(es)
*
|
2008-02-25 |
2012-01-27 |
F. Hoffmann-La Roche Ag |
Inhibidores de la pirrolopirazina quinasa.
|
|
WO2010008864A2
(en)
*
|
2008-06-24 |
2010-01-21 |
Amira Pharmaceuticals, Inc. |
Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors
|
|
CA2730606A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
DE102008039082A1
(de)
|
2008-08-21 |
2010-02-25 |
Bayer Schering Pharma Aktiengesellschaft |
Azabicyclisch-substituierte 5-Aminopyrazole und ihre Verwendung
|
|
TWI368513B
(en)
*
|
2009-04-30 |
2012-07-21 |
Univ Kaohsiung Medical |
Synthesis of pulmodil and pulmodil-1, two chlorophenylpiperazine salt derivatives, and rhokinase-dependent inhibition activity on pulmonary artery endothelium dysfunction, medial wall thickness and vascular obstruction thereof
|
|
WO2011111880A1
(ko)
|
2010-03-08 |
2011-09-15 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
|
MX2013000103A
(es)
*
|
2010-06-23 |
2013-06-13 |
Vertex Pharma |
Derivados de pirrolo-pirazina utiles como inhibidores de cinasa art.
|
|
PT2593452T
(pt)
|
2010-07-14 |
2017-04-24 |
Novartis Ag |
Compostos heterocíclicos agonistas do receptor ip
|
|
US9174985B2
(en)
|
2012-01-13 |
2015-11-03 |
Novartis Ag |
Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
|
|
US20150005311A1
(en)
|
2012-01-13 |
2015-01-01 |
Novartis Ag |
IP receptor agonist heterocyclic compounds
|
|
US9115129B2
(en)
|
2012-01-13 |
2015-08-25 |
Novartis Ag |
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists
|
|
UY34572A
(es)
|
2012-01-13 |
2013-09-02 |
Novartis Ag |
Compuestos heterocíclicos agonistas del receptor ip
|
|
US20140357641A1
(en)
|
2012-01-13 |
2014-12-04 |
Novartis Ag |
IP receptor agonist heterocyclic compounds
|
|
WO2013105058A1
(en)
|
2012-01-13 |
2013-07-18 |
Novartis Ag |
7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|